CanSino shares rise in first day of Hong Kong trading

CanSino rose HK$12.70 (58%) to HK$34.70 in its first day of trading Thursday after raising HK$1.3 billion (US$160.5 million) in its IPO. The performance may signal renewed confidence in China’s domestic vaccine companies.

CanSino Biologics Inc. (HKSE:6185) priced the offering Wednesday at the top of its proposed range (see "CanSino Raises $161M in Hong Kong IPO")...